Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rani Therapeutics Holdings (RANI) Receivables - Other (2020 - 2024)

Rani Therapeutics Holdings' Receivables - Other history spans 1 years, with the latest figure at $400000.0 for Q4 2024.

  • On a quarterly basis, Receivables - Other changed N/A to $400000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $400000.0, a N/A change, with the full-year FY2024 number at $400000.0, changed N/A from a year prior.
  • Receivables - Other came in at $400000.0 for Q4 2024.
  • The five-year high for Receivables - Other was $400000.0 in Q4 2024, with the low at $400000.0 in Q4 2024.